Business Context and Reporting Period
This Form 8-K is a current report filed by DarioHealth Corp. on July 10, 2026. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol DRIO. The report addresses a specific corporate governance event regarding senior management.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the extension of the temporary medical leave of absence for Steven Nelson, the Company's President and Chief Commercial Officer. The leave has been extended for an indefinite period effective July 10, 2026.
Management Commentary and Operational Impact
- Leadership Transition: During Mr. Nelson's indefinite leave, his responsibilities are being assumed by members of the Company's senior management team.
- Outlook and Risks: The filing does not provide specific guidance, outlook, or detailed risk factors beyond the operational impact of the executive's absence.
Investor Verification Checklist
- Verify the duration and terms of Steven Nelson's medical leave extension.
- Identify which specific senior management members are assuming the President and Chief Commercial Officer duties.
- Monitor future filings for any updates on Mr. Nelson's return or potential permanent leadership changes.
- Review subsequent quarterly reports (10-Q) or annual reports (10-K) for financial performance data, as this 8-K contains none.